申万菱信中证申万医药生物指数A(163118)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2023/3/31 |
273,325,000 |
- |
293,984,000 |
292,500,000 |
93% |
2022/12/31 |
275,392,000 |
- |
295,902,000 |
293,913,000 |
94% |
2022/9/30 |
248,876,000 |
- |
268,422,000 |
265,814,000 |
94% |
2022/6/30 |
259,565,000 |
- |
278,923,000 |
277,296,000 |
94% |
2022/3/31 |
248,220,000 |
- |
266,672,000 |
265,641,000 |
93% |
2021/12/31 |
263,593,000 |
- |
282,612,000 |
281,616,000 |
94% |
2021/9/30 |
261,417,000 |
- |
280,979,000 |
279,542,000 |
94% |
2021/6/30 |
291,082,000 |
- |
316,775,000 |
312,462,000 |
93% |
2021/3/31 |
278,486,000 |
- |
298,808,000 |
297,360,000 |
94% |
2021/1/18 |
307,405,000 |
- |
331,817,000 |
327,233,000 |
94% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。